ClinicalTrials.Veeva

Menu

Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying

U

University of Bari

Status and phase

Completed
Phase 4

Conditions

Regurgitation, Gastric

Treatments

Dietary Supplement: HA formula + starch + L. reuteri

Study type

Interventional

Funder types

Other

Identifiers

NCT01956682
University of Bari

Details and patient eligibility

About

The primary objective of this trial is to show that an hypoallergenic infant starter formula containing starch and the probiotic L. reuteri decreases the severity of regurgitation/spitting-up in infants presenting regurgitation/spitting-up , and who have taken it for 4 weeks, in comparison with a standard infant starter formula.

Full description

The primary objective of this trial is to show that the test formula (HA formula + starch + L. reuteri) decreases the severity (frequency + volume) of regurgitation/spitting-up in infants and ultrasound gastric emptying time, compared to a classical infant starter formula.

Enrollment

132 patients

Sex

All

Ages

5 days to 5 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Full term infant (37 weeks ≤ gestation ≤ 42 weeks)
  • Age of infant between 5 days and 5 months
  • NGA
  • Infant exclusively formula-fed at enrollment
  • Presenting regurgitation/spitting-up according to the parents' perception
  • Vandenplas score of at least 2 and maximum 5
  • Having obtained the subject's legal representative's written informed consent

Exclusion criteria

  • Previous antireflux treatment
  • Previous consumption of AR infant formula or external thickener
  • Previous consumption of a formula with L. reuteri
  • Cow's milk allergy symptoms according to medical decision
  • Congenital illness or malformation that may affect growth
  • Significant pre-natal and/or post-natal disease
  • Newborn whose parents / caregivers cannot be expected to comply with study procedures
  • Newborn currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

132 participants in 2 patient groups, including a placebo group

Infant formula
Active Comparator group
Description:
HA formula + starch + L. reuteri
Treatment:
Dietary Supplement: HA formula + starch + L. reuteri
Standard Formula
Placebo Comparator group
Description:
Standard Infant Formula

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems